Ann: Quarterly Report and Appendix 4C, page-2

Not a great quarter for revenues, but cashflow looking good

If they can get NZ and UK up and running then the Medadvisor app is finally making some money, and the US business will be lumpy, but if they can transition that to digital (higher margins) and retain annualised revenues of ~AUD50m, then you have a decent business that is worth lot more than 100m when you consider the revenues from digital programs from the pharma companies

Would have also like to have seen them reconfirm the guidance as well as their ambition of being cashflow positive (without delayed payments etc)